文献速递泌尿系感染前列腺增生与排尿功能障碍

基于症状的患者选择与检测者经验可显著提高Meares & Stamey试验的诊断阳性率

The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-03-30

这项回顾性队列研究分析了2004年1月至2021年12月两个泌尿中心9347例接受Meares-Stamey四杯试验的患者,按症状分为仅前列腺炎相关、前列腺炎合并良性前列腺增生相关、仅良性前列腺增生相关三组。仅前列腺炎症状组阳性率81.4%,合并症状组29.0%,仅良性前列腺增生症状组34.4%;设有前列腺炎专职人员的中心阳性率64.3%,显著高于普通泌尿科中心的31.4%(p < 0.001)。结论认为基于症状的患者选择和专职人员可提高该试验的诊断阳性率并减少不必要的检测。

要点

  • 仅前列腺炎症状组M&S试验阳性率81.4%,合并症状组29.0%,仅BPH症状组34.4%。
  • 设有前列腺炎专职人员的中心阳性率64.3%,显著高于普通泌尿科中心的31.4%(p < 0.001)。
  • 最常见分离菌种为大肠埃希菌(49.7%),其次为肠球菌属(31.8%)。

核心结论

  • 基于症状的患者选择和专职人员可提高M&S试验的诊断阳性率并减少不必要的检测。

研究设计与样本

  • 回顾性队列研究,分析2004年1月至2021年12月两个泌尿中心接受M&S试验的9347例患者的临床和微生物学数据。
  • 一个中心设有前列腺炎研究专职人员(队列I),另一个为普通泌尿科单位(队列II)。
  • 按症状将患者分为三组:仅前列腺炎相关症状(组I,1884例)、前列腺炎和BPH相关症状(组II,5151例)、仅BPH相关症状(组III,2312例)。

主要发现

  • 最常见分离菌种为大肠埃希菌(49.7%),其次为肠球菌属(31.8%)。
  • 各症状组M&S试验阳性率:组I 1532例(81.4%),组II 1494例(29.0%),组III 797例(34.4%)。
  • 队列I(有前列腺炎专职人员的中心)阳性率64.3%,显著高于队列II(普通泌尿科)的31.4%(p < 0.001)。

临床怎么用

  • 作者认为基于症状的患者选择和专职人员可提高M&S试验诊断阳性率并减少不必要的检测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Even if Meares-Stamey 4-glass (M&S) test is regarded a decisive tool for diagnosing prostatitis its use is only rarely performed in everyday clinical practice. Here, we analyze if the diagnostic yield of the M&S test could be improved by a pre-test categorization of patients due to undergo a M&S test. METHODS: All clinical and microbiological data of patients who underwent M&S test in two urological centers from January 2004 to December 2021 were analyzed in this retrospective cohort study. One center has a dedicated staff member for the study of prostatitis (Cohort I), while the other center is a general urological unit (Cohort II). All patients were divided into 3 groups on the basis of the assembled data: patients with symptoms related to prostatitis only (Group I), patients with symptoms related to both prostatitis and BPH (Group II), patients with symptoms related to BPH only (Group III). The rates of positive microbiological results in each group were compared. RESULTS: In the whole period, 9347 patients were analyzed and categorized as follows: Group I, 1884; Group II, 5151; Group III, 2312. Three-thousand and eight-hundred twenty-three patients showed positive culture results (40.9%). The most common isolated species was Escherichia coli (49.7%), followed by Enteroccus spp. (31.8%). The rates of positive M&S tests in the different symptom groups were: Group I, 1532 (81.4%); Group II, 1494 (29.0%); Group III, 797 (34.4%). The overall rate of positive M&S tests in each urology center showed that the center with a staff member who is dedicated to prostatitis studies (Cohort I) had a significantly higher rate of positive M&S tests than the general urological department (Cohort II) (64.3% vs 31.4%; p < 0.001). CONCLUSIONS: Symptom-based patient selection and dedicated staff members will increase the diagnostic yield of the M&S test and reduce the number of unnecessary tests.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Cai T, Tamanini I, Odorizzi K, et al. The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer. Prostate Cancer Prostatic Dis. 2024. PMID: 38555411. doi:10.1038/s41391-024-00824-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。